UBS Maintains a 'Neutral' on Molina Healthcare (MOH); Investor Day Takeaways
Tweet
Share
E-mailGet Alerts MOH Hot Sheet
Price: $196.94 -2.1%
Rating Summary:
11 Buy, 19 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
11 Buy, 19 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
UBS maintains a 'Neutral' on Molina Healthcare (NYSE: MOH) price target lowered by $3 to $18.
UBS analyst says, "MOH recently hosted its semi-annual investor day where presentations incl health plan/financial updates, as well as the potential dual eligible integration opportunity. MOH’s 2011 EPS outlook unchanged at ~$1.55 (which includes -6% CA rate impact from provider fee schedule cuts) w/co deferring updated 2012 outlook until January. Notably, mgmt addressed recent publicly-traded hospital commentary around Medicaid volumes and highlighted that MOH’s hospital utilization continues to be down YoY (although AMERIGROUP (NYSE: AGP) cited higher med costs at its 9/16 I-day)."
"MOH's flat-to-down outlook largely consistent w/peers with MOH awaiting clarity on key WA (10/1 effective date), MI (10/1), and CA (10/1) markets. While we leave our 2011 EPS at $1.56, we modestly lower our 2012 EPS est to $1.75 (from $1.80) which assumes no incremental RFP wins and that co retains existing biz."
For more ratings news on Molina Healthcare click here and for the rating history of Molina Healthcare click here.
Shares of Molina Healthcare closed at $16.92 yesterday.
UBS analyst says, "MOH recently hosted its semi-annual investor day where presentations incl health plan/financial updates, as well as the potential dual eligible integration opportunity. MOH’s 2011 EPS outlook unchanged at ~$1.55 (which includes -6% CA rate impact from provider fee schedule cuts) w/co deferring updated 2012 outlook until January. Notably, mgmt addressed recent publicly-traded hospital commentary around Medicaid volumes and highlighted that MOH’s hospital utilization continues to be down YoY (although AMERIGROUP (NYSE: AGP) cited higher med costs at its 9/16 I-day)."
"MOH's flat-to-down outlook largely consistent w/peers with MOH awaiting clarity on key WA (10/1 effective date), MI (10/1), and CA (10/1) markets. While we leave our 2011 EPS at $1.56, we modestly lower our 2012 EPS est to $1.75 (from $1.80) which assumes no incremental RFP wins and that co retains existing biz."
For more ratings news on Molina Healthcare click here and for the rating history of Molina Healthcare click here.
Shares of Molina Healthcare closed at $16.92 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades John B. Sanfilippo & Son, Inc. (JBSS) to Buy
- Hims and Hers (HIMS) PT Lowered to $35 at Barclays
- GLJ Research Downgrades Fluence Energy Inc. (FLNC) to Hold
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
